5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.39▲ | 1.39▲ | 1.38▲ | 1.46▼ | 1.62▼ |
MA10 | 1.38▲ | 1.38▲ | 1.42▼ | 1.51▼ | 2.11▼ |
MA20 | 1.38▲ | 1.44▼ | 1.48▼ | 1.66▼ | 3.36▼ |
MA50 | 1.40▲ | 1.50▼ | 1.49▼ | 2.26▼ | 31.61▼ |
MA100 | 1.49▼ | 1.51▼ | 1.58▼ | 4.01▼ | 23.88▼ |
MA200 | 1.54▼ | 1.68▼ | 1.86▼ | 36.69▼ | 44.89▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.006▲ | -0.002▼ | -0.016▼ | 0.030▲ | 1.427▲ |
RSI | 57.532▲ | 45.522▼ | 45.547▼ | 27.764▼ | 35.731▼ |
STOCH | 100.000▲ | 48.122 | 15.079▼ | 10.712▼ | 4.403▼ |
WILL %R | 0.000▲ | -52.778 | -93.796▼ | -93.885▼ | -99.279▼ |
CCI | 176.458▲ | 19.152 | -54.187 | -119.539▼ | -71.074 |
Tuesday, September 16, 2025 11:16 AM
Despite its proven technology, high-margin model, and growing adoption across critical industries, TOMI Environmental Solutions (NASDAQ: TOMZ) remains significantly undervalued. The company’s growth ...
|
Tuesday, September 16, 2025 07:31 AM
Aptevo Therapeutics (NASDAQ:APVO) saw its stock jump 57% on Tuesday after announcing that Cohort 3 of its Phase 1b/2 RAINIER trial for acute myeloid leukemia (AML) achieved a 100% remission rate. The ...
|
Tuesday, September 16, 2025 06:58 AM
Investing.com -- Aptevo Therapeutics (NASDAQ:APVO) stock surged 57% Tuesday after the clinical-stage biotechnology company announced a 100% remission rate in Cohort 3 of its Phase 1b/2 RAINIER trial ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
17/09/25 | 1.50 | 1.50 | 1.32 | 1.405 | 4,143,905 |
16/09/25 | 2.20 | 2.71 | 1.42 | 1.50 | 114,369,560 |
15/09/25 | 1.50 | 1.52 | 1.40 | 1.44 | 218,425 |
12/09/25 | 1.51 | 1.5424 | 1.43 | 1.47 | 256,332 |
11/09/25 | 1.53 | 1.54 | 1.46 | 1.50 | 220,170 |
10/09/25 | 1.52 | 1.5576 | 1.46 | 1.50 | 278,271 |
09/09/25 | 1.53 | 1.5835 | 1.48 | 1.53 | 239,562 |
08/09/25 | 1.59 | 1.60 | 1.48 | 1.48 | 258,506 |
05/09/25 | 1.63 | 1.6399 | 1.54 | 1.61 | 144,451 |
04/09/25 | 1.69 | 1.6922 | 1.56 | 1.63 | 178,767 |
|
|
||||
|
|
||||
|
|